Form 4 for UTHR UNITED THERAPEUTICS Corp
Accepted 2026-05-07 16:31:19 ET · period of report 2026-05-07 · accession 0001231589-26-000011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-05-07 16:31 | 2026-05-07 | UTHR | MAHON PAUL A | EVP, GC | M - OptEx | $146.03 | +8,300 | 53.5K | +18% | +$1.21M |
| DMT | 2026-05-07 16:31 | 2026-05-07 | UTHR | MAHON PAUL A | EVP, GC | S - Sale+OE | $586.75 | -8,300 | 45.2K | -16% | -$4.87M |
| DT | 2026-05-07 16:31 | 2026-05-07 | UTHR | MAHON PAUL A | EVP, GC | M - OptEx | $0.00 | -8,300 | 300 | -97% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-07 | M | A | 8,300 | $146.03 | 53,472 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. |
| 2 | Common | Common Stock | 2026-05-07 | S | D | 80 | $582.86 | 53,392 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. (F2) This transaction was executed in multiple trades at prices ranging from $582.42 to $583.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2026-05-07 | S | D | 1,475 | $584.07 | 51,917 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. (F3) This transaction was executed in multiple trades at prices ranging from $583.72 to $584.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Common | Common Stock | 2026-05-07 | S | D | 994 | $585.18 | 50,923 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. (F4) This transaction was executed in multiple trades at prices ranging from $584.83 to $585.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Common | Common Stock | 2026-05-07 | S | D | 1,689 | $586.17 | 49,234 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. (F5) This transaction was executed in multiple trades at prices ranging from $585.86 to $586.695. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 6 | Common | Common Stock | 2026-05-07 | S | D | 2,970 | $587.61 | 46,264 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. (F6) This transaction was executed in multiple trades at prices ranging from $587.185 to $588.105. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 7 | Common | Common Stock | 2026-05-07 | S | D | 820 | $588.51 | 45,444 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. (F7) This transaction was executed in multiple trades at prices ranging from $588.195 to $588.7025. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 8 | Common | Common Stock | 2026-05-07 | S | D | 70 | $596.19 | 45,374 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. |
| 9 | Common | Common Stock | 2026-05-07 | S | D | 202 | $597.54 | 45,172 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. |
| 10 | Derivative | Stock Option | 2026-05-07 | M | D | 8,300 | $0.00 | 300 | D | $146.03 · 2020-03-15 to 2027-03-15 | 8,300 Common Stock | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. |